TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $132,381 | -84.6% | 454,916 | 0.0% | 0.00% | -88.9% |
| Q1 2023 | $859,791 | +26.8% | 454,916 | 0.0% | 0.01% | +28.6% |
| Q4 2022 | $677,825 | -10.8% | 454,916 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $760,000 | -16.5% | 454,916 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $910,000 | -23.9% | 454,916 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $1,196,000 | +52.0% | 454,916 | +60.0% | 0.01% | +40.0% |
| Q4 2021 | $787,000 | -28.5% | 284,248 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $1,100,000 | -40.4% | 284,248 | 0.0% | 0.01% | -40.0% |
| Q2 2021 | $1,845,000 | -21.1% | 284,248 | 0.0% | 0.01% | -41.2% |
| Q1 2021 | $2,339,000 | -29.7% | 284,248 | 0.0% | 0.02% | -32.0% |
| Q4 2020 | $3,326,000 | +126.3% | 284,248 | 0.0% | 0.02% | +38.9% |
| Q3 2020 | $1,470,000 | +163.9% | 284,248 | 0.0% | 0.02% | +100.0% |
| Q2 2020 | $557,000 | +17.3% | 284,248 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $475,000 | -28.6% | 284,248 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $665,000 | – | 284,248 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |